Skip to main content
Equibles
LNTH logo

LNTH · Lantheus Holdings, Inc. · Metrics

Track LNTH — free

Use LNTH with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research LNTH.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$99.96 +0.31 (+0.31%) At close · Oct 2
S&P 400 member Russell 2000 member Rebalance outlook locked
Market Cap
$6.51B
Shares
65.27M
Volume · Oct 2 714.69K Avg daily vol (3M) 1.34M

LNTH metrics

80 of 115 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$99.96
Market cap
$6.51B

Price action

20 metrics
Price change (1W)
-0.1%
Price change (30D)
-1.2%
Price change (3M)
-9.3%
Price change (6M)
+30.9%
Price change (YTD)
+49.7%
Price change (1Y)
+93.0%
Trailing year
Price change (5Y)
+285.2%
52-week high
$110.94
52-week low
$50.69
Change from 52-week high
-10.2%
Change from 52-week low
+96.6%
Annualized volatility
33.5%
Annualized volatility (3M)
24.6%
Beta
0.6
RSI (14D)
39.8
Price vs SMA 50
-1.2%
Price vs SMA 200
+13.4%
Avg volume (3M)
1.34M
Relative volume
0.5
Average dollar volume
$135.43M

Company

3 metrics
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Shares outstanding
65.27M

Valuation

12 metrics
P / E (TTM)
23.8
Trailing earnings · reciprocal yield 4.2%
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
4.2×
reciprocal yield 23.9%
P / book
5.0
reciprocal yield 20.1%
FCF yield
—
TTM · current market cap
Buyback yield
3.1%
P / FCF
—
P / operating cash flow
15.8
reciprocal yield 6.3%
Earnings yield
4.2%

Historical valuation

8 metrics
P / E historical average (3Y)
20.7×
reciprocal yield 4.8%
P / E historical average (5Y)
49.3×
reciprocal yield 2.0%
EV / revenue historical average (3Y)
3.6×
reciprocal yield 27.9%
EV / revenue historical average (5Y)
4.6×
reciprocal yield 21.8%
EV / EBIT historical average (3Y)
19.0×
reciprocal yield 5.3%
EV / EBIT historical average (5Y)
39.5×
reciprocal yield 2.5%
EV / EBITDA historical average (3Y)
14.6×
reciprocal yield 6.9%
EV / EBITDA historical average (5Y)
54.7×
reciprocal yield 1.8%

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
3.1%
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-08-06

Profitability

9 metrics
Gross margin
60.1%
Operating margin
19.4%
Trailing 12 months
Net margin
17.7%
Gross profit (TTM)
$936.02M
Operating profit (TTM)
$302.34M
Net income (TTM)
$275.31M
Trailing 12 months
Diluted EPS (TTM)
$4.18
FCF margin
—
Effective tax rate
24.2%

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
$16.87

Growth

11 metrics
Revenue growth YoY
+2.7%
Year over year
Net income growth YoY
-4.7%
Revenue (TTM)
$1.56B
Trailing 12 months
EPS growth YoY
-0.9%
Shares change YoY
-4.0%
Year over year · fewer shares
Revenue CAGR (3Y)
+18.1%
Revenue CAGR (5Y)
+35.3%
EPS CAGR (3Y)
+104.3%
EPS CAGR (5Y)
—
FCF CAGR (3Y)
+151.2%
FCF CAGR (5Y)
+44.6%

Quality

14 metrics
Return on equity
21.0%
Return on assets
11.4%
Debt / equity
—
Current ratio
3.1
EBITDA (TTM)
$390.85M
Free cash flow (TTM)
—
Quick ratio
2.9
Interest coverage
15.3
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Cash & equivalents
$593.30M
Total assets
$2.41B
Total debt
—

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$412.80M
Capital expenditures (TTM)
$45.34M
R&D (TTM)
$173.09M
SG&A (TTM)
—
Stock compensation (TTM)
$78.09M
R&D / revenue
11.1%
Stock compensation / revenue
5.0%

Ownership (13F)

3 metrics
13F filers
469
13F filer change QoQ
+60
Institutional ownership
116.1%

Short interest

3 metrics
Short interest
6.2%
Latest settlement · 4.1 days to cover
Days to cover
4.1d
Short-squeeze score
60 / 100

Insider activity

2 metrics
Net insider buying (90D)
—
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
—
Key facts CIK 1521036 CUSIP 516544103 13F (30d) 21 filings 11 filers Visit website Investor relations